» Articles » PMID: 16306342

Is Latent Autoimmune Diabetes in Adults Distinct from Type 1 Diabetes or Just Type 1 Diabetes at an Older Age?

Overview
Journal Diabetes
Specialty Endocrinology
Date 2005 Nov 25
PMID 16306342
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetes is classified clinically into two types: type 1 and type 2 diabetes. Type 1 diabetes is an autoimmune diabetes, whereas, in contrast, type 2 diabetes is nonautoimmune. However, there is a group of phenotypic adult type 2 diabetic patients ( approximately 10%) who have islet autoantibodies similar to type 1 diabetes. These patients are said to have latent autoimmune diabetes in adults (LADA) or type 1.5 diabetes. T-cells reacting with islet proteins have been demonstrated in type 1 and type 1.5 diabetic patients. In contrast, classic autoantibody-negative type 2 diabetic patients are also negative for T-cell responses to islet proteins. Therefore, we questioned whether type 1 and type 1.5 diabetes are similar or different autoimmune diseases. We have investigated the immunological and metabolic differences between type 1, type 1.5, and classic type 2 diabetic patients. We have identified autoantibody differences, differences in islet proteins recognized by T-cells, and differences in insulin resistance. We have also identified a small group of patients who have T-cells responsive to islet proteins but who are autoantibody negative. These patients appear to be similar to type 1.5 patients in having decreased stimulated C-peptide values. These immunological differences between type 1 and type 1.5 diabetes suggest at least partially distinct disease processes.

Citing Articles

The epidemiology of type 1 diabetes mellitus in older adults.

Tomic D, Harding J, Jenkins A, Shaw J, Magliano D Nat Rev Endocrinol. 2024; 21(2):92-104.

PMID: 39448829 DOI: 10.1038/s41574-024-01046-z.


Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus.

Sacks D, Arnold M, Bakris G, Bruns D, Horvath A, Lernmark A Diabetes Care. 2023; 46(10):e151-e199.

PMID: 37471273 PMC: 10516260. DOI: 10.2337/dci23-0036.


Future number of people with diagnosed type 1 diabetes in Germany until 2040: an analysis based on claims data.

Voeltz D, Brinks R, Tonnies T, Hoyer A BMJ Open Diabetes Res Care. 2023; 11(2).

PMID: 37024151 PMC: 10083786. DOI: 10.1136/bmjdrc-2022-003156.


Latent Autoimmune Diabetes in Adults and Metabolic Syndrome-A Mini Review.

Pan N, Yang S, Niu X Front Endocrinol (Lausanne). 2022; 13:913373.

PMID: 35837301 PMC: 9273866. DOI: 10.3389/fendo.2022.913373.


Anti-diabetics and antimicrobials: Harmony of mutual interplay.

Hegazy W, Rajab A, Lila A, Abbas H World J Diabetes. 2021; 12(11):1832-1855.

PMID: 34888011 PMC: 8613656. DOI: 10.4239/wjd.v12.i11.1832.